• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Reported Earlier, Gildan Activewear Boosts Normal Course Issuer Bid To Repurchase Up To 10% Of Public Float Or ~17.12M Common Shares

    5/30/24 3:19:56 AM ET
    $GIL
    Apparel
    Consumer Discretionary
    Get the next $GIL alert in real time by email

    As such, Gildan today announced that it has received approval from the Toronto Stock Exchange (TSX) to amend its current NCIB, which commenced on August 9, 2023, in order to increase the maximum number of common shares that may be repurchased from 8,778,638, or 5% of its issued and outstanding common shares as at July 31, 2023 (the reference date for the NCIB), to 17,124,249 common shares, representing 10% of the public float as at July 31, 2023. No other terms of the NCIB have been amended.

    Get the next $GIL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GIL

    DatePrice TargetRatingAnalyst
    4/28/2025$51.00Overweight
    Barclays
    1/10/2025$50.00 → $60.00Neutral → Buy
    UBS
    8/2/2024Hold → Buy
    Stifel
    1/5/2024Buy → Neutral
    UBS
    12/7/2023Buy → Hold
    Edward Jones
    8/4/2023$36.00 → $38.00Hold → Buy
    TD Securities
    5/2/2023$38.00Buy
    Stifel
    1/23/2023Buy → Hold
    TD Securities
    More analyst ratings